Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research8

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research8

FiltersClear all

Status

Recruiting5
Active, not recruiting1
Completed2

Study type

Interventional8

Phase

Phase 33
Not applicable3
Phase 11
Phase 21

Investigator

Jim C. Hu3
Cora Sternberg1
Douglas S Scherr1
Hani Lamie Ashamalla1
Michelle S. Bradbury1

Department

Urology4
Medicine2
Pharmacology1
Radiation Oncology1

Condition

Prostatic Neoplasms8
Breast Neoplasms8
Urinary Bladder Neoplasms6
Burkitt Lymphoma5
Carcinoma, Renal Cell5

Intervention type

Procedure8
Drug36
Radiation11
Other10
Diagnostic test7
Biological4

Sponsor type

Other academic3
WCM (investigator-initiated)3
Cooperative group1
NIH1

Start date

Has results posted2

Prostatic Neoplasms×Procedure×Clear all

Showing 1–8 of 8 studiesSort:

RecruitingInterventional · Phase 3NCT03678025 ↗
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer

FiltersClear all

Status

Recruiting5
Active, not recruiting1
Completed2

Study type

Interventional8

Phase

Phase 33
Not applicable3
Phase 11
Phase 21

Investigator

Jim C. Hu3
Cora Sternberg1
Douglas S Scherr1
Hani Lamie Ashamalla1
Michelle S. Bradbury1

Department

Urology4
Medicine2
Pharmacology1
Radiation Oncology1

Condition

Prostatic Neoplasms8
Breast Neoplasms8
Urinary Bladder Neoplasms6
Burkitt Lymphoma5
Carcinoma, Renal Cell5

Intervention type

Procedure8
Drug36
Radiation11
Other10
Diagnostic test7
Biological4

Sponsor type

Other academic3
WCM (investigator-initiated)3
Cooperative group1
NIH1

Start date

Has results posted2

Prostatic Neoplasms×Procedure×Clear all

Showing 1–8 of 8 studiesSort:

RecruitingInterventional · Phase 3NCT03678025 ↗
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer

Show all 6

Show fewer

Scott T. Tagawa1

Show all 50

Show fewer

Carcinoma, Transitional Cell4
Leukemia, Myeloid, Acute4
Neoplasm Metastasis4
Carcinoma, Non-Small-Cell Lung3
Carcinosarcoma3
Crohn Disease3
Infections3
Leukemia, Biphenotypic, Acute3
Lung Neoplasms3
Myelodysplastic Syndromes3
Myeloproliferative Disorders3
Parkinson Disease3
Triple Negative Breast Neoplasms3
Adenocarcinoma Of Esophagus2
Atrial Fibrillation2
Brain Neoplasms2
Colorectal Neoplasms2
Coronary Artery Disease2
Endometrial Neoplasms2
Hematologic Neoplasms2
Kyphosis2
Leukemia, Myelomonocytic, Chronic2
Melanoma2
Mycosis Fungoides2
Myelodysplastic-Myeloproliferative Diseases2
Osteoarthritis2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2
Rectal Neoplasms2
Scoliosis2
Sezary Syndrome2
Urethral Neoplasms2
Anemia, Refractory, with Excess of Blasts1
Arthritis, Psoriatic1
Arthritis, Rheumatoid1
Ataxia1
Atrial Flutter1
Autoimmune Diseases1
Breast Carcinoma In Situ1
Bundle-Branch Block1
Burns1
Carcinoma1
Cardiomyopathies1

Device3

Behavioral1

Douglas S ScherrPI

Intervention: Drug: Abiraterone · Drug: Bicalutamide · Drug: Degarelix · Drug: Docetaxel · Drug: Flutamide · Drug: Goserelin Acetate · Drug: Histrelin Acetate · Drug: Leuprolide Acetate · Drug: Nilutamide · Procedure: Orchiectomy · Drug: Prednisone · Other: Quality-of-Life Assessment · Radiation: Radiation Therapy · Procedure: Radical Prostatectomy · Drug: Triptorelin
Dates: Sep 2018 – Apr 2033 (est.)
Sponsor: Southwest Oncology Group

Castration Levels of TestosteroneMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more

RecruitingInterventional · Phase 2NCT03866382 ↗

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)

Cora SternbergPI

Intervention: Procedure: Biospecimen Collection · Procedure: Bone Scan · Drug: Cabozantinib S-malate · Procedure: Computed Tomography · Procedure: Echocardiography Test · Biological: Ipilimumab · Procedure: Magnetic Resonance Imaging · Biological: Nivolumab · Procedure: Positron Emission Tomography
Dates: May 2019 – Feb 2027 (est.)
Sponsor: Alliance for Clinical Trials in Oncology

Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more

RecruitingInterventional · Phase 1NCT04167969 ↗

Molecular Phenotyping and Image-Guided Surgical Treatment of Prostate Cancer Using Ultrasmall Silica Nanoparticles

Michelle S. BradburyPI

Intervention: Drug: (64Cu)-NOTA-PSMAi-PEG-Cy5.5-C' dot tracer · Diagnostic test: PET/MRI/fluorescence imaging · Other: Blood and urine sampling · Procedure: laparoscopic radical prostatectomy and bilateral pelvic LN dissection or a salvage lymph node dissection · Drug: 89Zr-DFO-PSMAi-PEG-Cy5.5-C' dots
Dates: Feb 2021 – Nov 2027 (est.)
Sponsor: Memorial Sloan Kettering Cancer Center

Prostate Cancer

Active, not recruitingInterventional · Phase 3NCT04513717 ↗

Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)

Scott T. TagawaPI

Intervention: Drug: Apalutamide · Drug: Bicalutamide · Procedure: Biospecimen Collection · Procedure: Bone Scan · Drug: Buserelin · Procedure: Computed Tomography · Drug: Degarelix · Drug: Flutamide · Drug: Goserelin · Drug: Histrelin · Drug: Leuprolide · Procedure: Magnetic Resonance Elastography · Procedure: Positron Emission Tomography · Other: Quality-of-Life Assessment · Other: Questionnaire Administration · Radiation: Radiation Therapy · Drug: Relugolix · Drug: Triptorelin
Dates: Jan 2021 – Dec 2033 (est.)
Sponsor: NRG Oncology

Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8

RecruitingInterventional · Not applicableNCT05155501 ↗

Clinical TrIAL of Approaches to Prostate cAncer suRgery

Jim C. HuPI

Intervention: Procedure: Robot-assisted radical prostatectomy (RP) · Procedure: Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP)
Dates: May 2023 – Jul 2028 (est.)
Sponsor: Weill Medical College of Cornell University

Prostate Cancer

RecruitingInterventional · Phase 3NCT05946213 ↗

The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer

Hani Lamie AshamallaPI

Intervention: Procedure: Biospecimen Collection · Procedure: Bone Scan · Procedure: Computed Tomography · Radiation: External Beam Radiation Therapy · Procedure: Magnetic Resonance Imaging · Procedure: Positron Emission Tomography · Other: Quality-of-Life Assessment · Other: Questionnaire Administration · Radiation: Stereotactic Body Radiation Therapy
Dates: Dec 2023 – Mar 2036 (est.)
Sponsor: NRG Oncology

Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8

CompletedInterventional · Not applicableNCT04815876 ↗

Randomized Trial Comparing Transperineal vs. Transrectal MRI-targeted Prostate Biopsy; Randomized Controlled Trial Assessing Transperineal Prostate Biopsy to Reduce Infection Complications

Jim C. HuPI

Intervention: Procedure: Transperineal MRI-guided prostate biopsy · Procedure: Transrectal MRI-guided prostate biopsy · Drug: Antibiotic (prophylaxis)
Dates: Jun 2021 – Oct 2025· Results posted
Sponsor: Weill Medical College of Cornell University

Infection

CompletedInterventional · Not applicableNCT04843566 ↗

Evaluation of Transperineal Biopsy Under Local Anesthesia, a Novel Approach to Decrease Post-Biopsy Infections and Improve Cancer Detection

Jim C. HuPI

Intervention: Procedure: Transperineal MRI-guided prostate biopsy · Procedure: Transrectal MRI-guided prostate biopsy · Drug: Antibiotic (prophylaxis)
Dates: Mar 2021 – Apr 2024· Results posted
Sponsor: Weill Medical College of Cornell University

Infection